It is a quaternary amine and therefore does not diffuse into atrovent drug classification blood, which prevents systemic side effects. Ipratropium atrovent drug classification also combined with albuterol (salbutamol) (trade names Combivent and Duoneb) for the treatment of obstructive lung diseases. It acts by blocking muscarinic receptors in the lung, inhibiting.

navigation, searchIpratropiumSystematic (IUPAC) name[8-methyl-8-(1-methylethyl)- atrovent drug classification oct-3-yl] 3-hydroxy-2-phenyl-propanoateIdentifiersCAS number 60205-81-4ATC code R01AX03 R03BB01PubChem 43232DrugBank APRD00537Chemical dataFormula C20H30NO3Mol. mass 389.457 g/molSMILES eMolecules & PubChemPharmacokinetic dataBioavailability ?Protein binding 0 to 9% in vitroMetabolism HepaticHalf life 2 hoursExcretion ?Therapeutic considerationsPregnancy cat. B(US)Legal status POM(UK)Routes InhalationIpratropium (as ipratropium bromide, trade name Atrovent) is an anticholinergic drug administered by atrovent drug classification for the treatment atrovent drug classification obstructive lung diseases. It acts by blocking muscarinic receptors in the lung, inhibiting bronchoconstriction and mucus secretion. It is a quaternary amine and therefore does not diffuse into the blood, which atrovent drug classification systemic side effects. atrovent drug classification is also combined with albuterol (salbutamol) (trade names Combivent and Duoneb) for the atrovent drug classification of obstructive lung diseases. It acts.

barrier, which prevents central side effects (anticholinergic syndrome).Ipratropium is also combined with fenoterol (trade names.